Combination of Opdivo and Yervoy had improved efficacy and durable response after four years in patients with advanced non-small cell lung cancer.
Denise Myshko
Advertisement
Articles by Denise Myshko
Advertisement
Latest Updated Articles
Opdivo-Yervoy Combination Could Benefit Patients with Non-Small Cell Lung CancerPublished: June 8th 2021 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Every FDA Oncology Approval From November 2025
2
Reflecting on My Sister’s Final Days After Years of Unexpected Rebounds
3
Chemo Side Effects for Breast Cancer Led to Weeks in the Hospital
4
First Annual Blood Cancer Heroes Honors Leaders, Advocates and Survivors
5
